Mr. Dimun is a serial entrepreneur with more than 30 years of successful operational, business development, and financial experience in the healthcare marketplace.  During the last 20 years, Mr. Dimun has been a founder, investor, director, and mentor to over 21 emerging growth medical enterprises that have matured to commercial status. Of these enterprises, four became public companies and eleven were acquired.

Since 2001, Mr. Dimun has served as Chairman and Founder of Nascent Enterprises, a group of medical industry entrepreneurs focused on successful commercialization of promising medical device inventions. From 1987 to 2001, he served as Executive Vice President & Chief Financial Officer and member of the BOD of Vital Signs, a publicly held anesthesia, respiratory and sleep apnea medical device business. GE Healthcare acquired Vital Signs in 2008 for approximately $900 million. Prior to 1991, Mr. Dimun held positions as a Certified Public Accountant with national accounting firms and served as Senior Vice President for an international merchant banking firm specializing in mergers & acquisitions.

Mr. Dimun has been a director of several public companies, including MELA Sciences, Vital Signs, Bionx Implants, Colorado MedTech, Photomedix, ISS Surgical Systems and other numerous privately held companies in the healthcare industry. He has also served on the Board of Advisors of the Rutgers University Technology Center & the Biomaterial Institute of Rutgers University and, through Nascent Enterprises, provides the University of Pennsylvania and other universities with entrepreneurial assistance to commercialize their medical technology.